The power of combinative capabilities: Facilitating the outcome of frequent innovation in pharmaceutical R&D projects |
| |
Authors: | Thomas Biedenbach |
| |
Institution: | Ume? School of Business, Ume? University, Ume?, Sweden |
| |
Abstract: | The purpose of this article is to investigate how organizations organize the early phases of research and development (R&D) projects in the pharmaceutical industry to achieve frequent innovation. The investigation was designed as a qualitative multiple case study. The analysis identified a standardized projectification of the preproject phases, leading to certain conflicts, such as a severe tension between dynamic, project, and multiproject capabilities, which hamper frequent innovation. Optimizing combinative capabilities to balance the capabilities triumvirate can provide powerful leverage and boost frequent innovation. |
| |
Keywords: | combinative capabilities dynamic capabilities project capabilities multiproject capabilities pharmaceutical innovation |
|
|